NCT04526782 2025-11-18ENCO-BRAFIntergroupe Francophone de Cancerologie ThoraciquePhase 2 Active not recruiting119 enrolled
NCT04892017 2025-10-10A Phase 1/2 Study of Inlexisertib (DCC-3116) in Patients With RAS/MAPK Pathway Mutant Solid TumorsDeciphera Pharmaceuticals, LLCPhase 1/2 Active not recruiting144 enrolled